LEADS BIOLABS-B (09887) Included in Hang Seng Composite Index and Added to Stock Connect List

Stock News

03/06

LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and added to the list of eligible securities for the Southbound Stock Connect program. The inclusion in both the Hang Seng Composite Index and the Stock Connect program represents significant recognition from the capital markets regarding the company's performance and value. It will permit qualified mainland Chinese investors to directly invest in the shares, which are listed on the Hong Kong Stock Exchange, through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect mechanisms. This inclusion is anticipated to broaden the company's investor base, enhance the trading liquidity of its shares, and further optimize the shareholder structure.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1188540988"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188540988\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188540988?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 17:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188540988","market":"nz","top_or_hot":-1,"title":"LEADS BIOLABS-B (09887) Included in Hang Seng Composite Index and Added to Stock Connect List","media":"Stock News","content":"<p>LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and added to the list of eligible securities for the Southbound Stock Connect program. The inclusion in both the Hang Seng Composite Index and the Stock Connect program represents significant recognition from the capital markets regarding the company's performance and value. It will permit qualified mainland Chinese investors to directly invest in the shares, which are listed on the Hong Kong Stock Exchange, through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect mechanisms. This inclusion is anticipated to broaden the company's investor base, enhance the trading liquidity of its shares, and further optimize the shareholder structure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEADS BIOLABS-B (09887) Included in Hang Seng Composite Index and Added to Stock Connect List</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEADS BIOLABS-B (09887) Included in Hang Seng Composite Index and Added to Stock Connect List\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-03-06 17:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and added to the list of eligible securities for the Southbound Stock Connect program. The inclusion in both the Hang Seng Composite Index and the Stock Connect program represents significant recognition from the capital markets regarding the company's performance and value. It will permit qualified mainland Chinese investors to directly invest in the shares, which are listed on the Hong Kong Stock Exchange, through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect mechanisms. This inclusion is anticipated to broaden the company's investor base, enhance the trading liquidity of its shares, and further optimize the shareholder structure.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HSCI","symbol_name":"恒生綜合指數","start_time":0,"source_url":"","article_id":"1188540988","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188540988","pubTimestamp":1772788704,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and added...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HSCI":"恒生综合指数","VT":"世界全股市ETF-Vanguard","HK0000252160.HKD":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元","BK4588":"碎股","BK1161":"生物科技","BK4585":"ETF&股票定投概念","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元","VXUS":"国际股票ETF-Vanguard","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元","09887":"维立志博-B"},"translate_title":"先导生物-B(09887)纳入恒生综合指数并加入沪股通名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HSCI":1,"VT":1,"09887":1,"VXUS":1},"content_text":"LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and added to the list of eligible securities for the Southbound Stock Connect program. The inclusion in both the Hang Seng Composite Index and the Stock Connect program represents significant recognition from the capital markets regarding the company's performance and value. It will permit qualified mainland Chinese investors to directly invest in the shares, which are listed on the Hong Kong Stock Exchange, through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect mechanisms. This inclusion is anticipated to broaden the company's investor base, enhance the trading liquidity of its shares, and further optimize the shareholder structure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}